"Teicoplanin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Glycopeptide antibiotic complex from Actinoplanes teichomyceticus active against gram-positive bacteria. It consists of five major components each with a different fatty acid moiety.
| Descriptor ID |
D017334
|
| MeSH Number(s) |
D09.400.420.900 D12.644.233.900
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Teicoplanin".
Below are MeSH descriptors whose meaning is more specific than "Teicoplanin".
This graph shows the total number of publications written about "Teicoplanin" by people in this website by year, and whether "Teicoplanin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Teicoplanin" by people in Profiles.
-
Dunne MW, Sahm D, Puttagunta S. Use of vancomycin as a surrogate for dalbavancin in vitro susceptibility testing: results from the DISCOVER studies. Ann Clin Microbiol Antimicrob. 2015 Apr 02; 14:19.
-
Arhin FF, Moeck G, Draghi DC, Pillar CM, Sahm DF. Longitudinal analysis of the in vitro activity profile of oritavancin and comparator glycopeptides against Gram-positive organisms from Europe: 2005-2008. Int J Antimicrob Agents. 2010 Nov; 36(5):474-6.
-
Arhin FF, Sarmiento I, Belley A, McKay GA, Draghi DC, Grover P, Sahm DF, Parr TR, Moeck G. Effect of polysorbate 80 on oritavancin binding to plastic surfaces: implications for susceptibility testing. Antimicrob Agents Chemother. 2008 May; 52(5):1597-603.
-
Goldstein BP, Draghi DC, Sheehan DJ, Hogan P, Sahm DF. Bactericidal activity and resistance development profiling of dalbavancin. Antimicrob Agents Chemother. 2007 Apr; 51(4):1150-4.
-
Jones ME, Gesu G, Ortisi G, Sahm DF, Critchley IA, Goglio A. Proficiency of Italian clinical laboratories in detecting reduced glycopeptide susceptibility in Enterococcus and Staphylococcus spp. using routine laboratory methodologies. Clin Microbiol Infect. 2002 Feb; 8(2):101-11.
-
Fines M, Perichon B, Reynolds P, Sahm DF, Courvalin P. VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405. Antimicrob Agents Chemother. 1999 Sep; 43(9):2161-4.
-
Hayden MK, Trenholme GM, Schultz JE, Sahm DF. In vivo development of teicoplanin resistance in a VanB Enterococcus faecium isolate. J Infect Dis. 1993 May; 167(5):1224-7.
-
Livornese LL, Gold M, Johnson CC, Measley R, Kaye D, Korzeniowski O, Walsh ML, Samel C, Hessen M, Levison ME. Clinical evaluation of teicoplanin in the treatment of gram-positive bacterial intravascular infections. J Antimicrob Chemother. 1993 Jan; 31(1):188-91.
-
Sahm DF, Kissinger J, Gilmore MS, Murray PR, Mulder R, Solliday J, Clarke B. In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis. Antimicrob Agents Chemother. 1989 Sep; 33(9):1588-91.